Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Sitting on Cash? These 2 Stocks Are Great Buys
05:30am, Tuesday, 11'th Jul 2023
Vertex Pharmaceuticals is already delivering billions of dollars in earnings annually, and a potential new product could offer more growth soon. Coca-Cola offers investors a growing passive income str
Want to Get Richer? 2 Unstoppable Stocks to Invest $1,000 In This Week
06:13am, Sunday, 09'th Jul 2023
The market is showing signs of investor optimism about the rest of 2023. Airbnb isn't banking only on traditional forms of travel -- it continues to innovate to meet the needs of every type of travele
3 No-Brainer Stocks You Can Buy Right Now
06:14am, Saturday, 08'th Jul 2023
Some investors are fearful about AbbVie right now, but it's better to be greedy with the stock. Pfizer offers a solid dividend and great growth prospects.
Vertex (VRTX) Gets Nod in EU for Orkambi Expanded Indication
12:20pm, Thursday, 06'th Jul 2023
Vertex's (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of cystic fibrosis in patients (aged 1 to
2 Growth Stocks That Might Be Too Cheap to Ignore
09:17am, Thursday, 06'th Jul 2023
Vertex Pharmaceuticals is starting to widen and diversify its lineup of medicines, which could make it even more successful than it already is. Teladoc remains down despite the progress it has made an
2 Supercharged Growth Stocks to Invest In Before the Next Bull Market
06:33am, Thursday, 06'th Jul 2023
Fintech and healthcare are two spaces on rapid growth trajectories. Upstart is growing on multiple key fronts that could pave the way for a very promising future.
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
08:24pm, Wednesday, 05'th Jul 2023
Investing in the biotech sector is mostly about risk and reward. When a company achieves FDA approval on a drug or therapeutic, it frequently has a source of revenue and profit that can last for years
The 3 Best Biotech Stocks to Buy In July
01:05pm, Wednesday, 05'th Jul 2023
Although it's been a difficult year for biotechnology stocks, there are still plenty of reasons for investors to be bullish on the sector. Many of the biggest innovations in medicine are occurring at
Vertex: Promising Prospects Amid Stretched Valuation
11:10pm, Tuesday, 04'th Jul 2023
Vertex Pharmaceuticals saw a 13% increase in Q1 2023 product revenue to $2.37 billion, primarily due to the robust uptake of its cystic fibrosis treatments. The company's net income fell due to higher
Vertex Pharmaceuticals Stock: Bear vs. Bull
05:30am, Monday, 03'rd Jul 2023
Vertex has climbed quite a bit this year -- and some potential good news may be priced in. Still, Vertex's late-stage programs offer it bright prospects down the road.
Vertex to Announce Second Quarter 2023 Financial Results on August 1
08:01am, Friday, 30'th Jun 2023
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2023 financial results on Tuesday, August 1, 2023 after the financial markets close. The comp
Buying These 3 Stocks Could Be the Smartest Investing Move You'll Ever Make
05:50am, Friday, 30'th Jun 2023
Amazon has major growth opportunities in AI, cloud services, and e-commerce. MercadoLibre dominates the Latin American e-commerce and fintech markets.
Weight-loss drugs in development aim to replace injections with pills
03:21pm, Monday, 26'th Jun 2023
Wall Street's obsession with next-generation obesity and diabetes treatments intensified over the weekend as drugmakers presented new clinical-trial data on the drugs — including weight-loss pills i
2 Unstoppable Growth Stocks That Could Turn $20,000 into $100,000 by 2030
05:39am, Tuesday, 20'th Jun 2023
Growth stock investing can be unpredictable from year to year, but long-term investors tend to outperform over time. Shares of Etsy are trading at a reasonable price that could soar in the years ahead
2 Market-Beating Stocks With Major Catalysts on the Way
10:07am, Saturday, 17'th Jun 2023
Vertex's next blockbuster could generate billions of dollars in sales. Biogen is inching closer to a goal it's been working on for a long time.
